Glycogen storage diseases: A brief review and update on clinical features, genetic abnormalities, pathologic features, and treatment

Ultrastructural Pathology

Volumn 35, Issue 5, 2011, Pages 183-196

  Hicks, John ^a   Wartchow, Eric ^b   Mierau, Gary ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

genetics; glycogen storage disease; molecular; pathology; ultrastructure

Indexed keywords

GLYCOGEN;

ANIMAL; ARTICLE; DISEASE MODEL; ENZYMOLOGY; GENETICS; GLYCOGEN STORAGE DISEASE; HUMAN; INFANT; LIVER; LIVER CELL; METABOLISM; NEWBORN; PATHOLOGY; PRENATAL DIAGNOSIS; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALS; DISEASE MODELS, ANIMAL; GLYCOGEN; GLYCOGEN STORAGE DISEASE; HEPATOCYTES; HUMANS; INFANT; INFANT, NEWBORN; LIVER; MICROSCOPY, ELECTRON, TRANSMISSION; PRENATAL DIAGNOSIS;

EID: 80052731002     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.3109/01913123.2011.601404     Document Type: Article

References (37)

1. Ozen H. Glycogen storage diseases: New perspectives. World J Gastroenterol. 2007;13(18):2541-2553.
2. DiMauro S, Bruno C. Glycogen storage disease of muscle. Curr Opin Neurol Neurosurg. 1998;11(5):477-484.
3. Wolfsdorf JI, Weinstein DA. Glycogen storage diseases. Rev Endocrinol Metab Disorders. 2003;4:95-102.
4. Wolsdorf JI, Holm IA, Weinstein DA. Glycogen storage disease: Phenotypic, genetic, and biochemical characteristics, and therapy. Endocrinol Metab Clin. 1999;28(4):802-824.
5. Jevon GP, Dimmick JE. Histopathologic approach to metabolic liver disease: Part 1. Pediatr Dev Pathol. 1998;1:179-199.
6. Roy A, Finegold MJ. Biopsy diagnosis of inherited liver disease. Surg Pathol Clin. 2010;3:743-768.
7. Koeberl DD, Kishnani PS, Chen YT. Glycogen storage disease types I and II: Treatment updates. J Inherit Metab Dis. 2007;30:159-164.
8. Janecke AR, Mayatepek E, Utermann G. Molecular genetics of type I glycogen storage disease. Mol Genet Metab. 2001;73:117-125.
9. Chou JY, Matern D, Mansfield BC, Chen Y-T. Type I glycogen storage disease: Disorders of the glucose-6-phosphatase complex. Curr Mol Med. 2002;2:121-143.
10. Chou JY. The molecular basis of type I glycogen storage diseases. Curr Mol Med. 2001;1:25-44.
11. Viega-da-Cunha M, Gerin I, Van Schaftingen E. How many forms of glycogen storage disease type I? Eur J Pediatr. 2000;159:314-318.
12. Yamaguchi T, Ihara K, Matsumoto T, et al. Inflammatory bowel disease-like colitis in glycogen storage disease type 1b. Inflammatory Bowel Dis. 2001;7(2):128-132.
13. Karasawa Y, Kobayashi M, Nakano Y, et al. A case of glycogen storage disease type 1a with multiple hepatic adenomas and G72T mutation in glucose-6-phosphatase gene, and a comparison with other mutations previously reported. Am J Gastroenterol. 1998;93(9):1550-1553.
14. Poenaru L. Approach to gene therapy of glycogenosis type II (Pompe disease). Mol Genet Metab. 2000;70:163-169.
15. Kishnani PS, Howell RR. Pompe disease in infants and children. J Pediatr. 2004;144:S35-S43.
16. Van den Hout HMP, Hop W, van Diggelens OP, et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics. 2003;112(2):332-340.
17. Lynch CM, Johnson J, Vaccaro C, Thurberg BL. High-resolution light microscopy (HRLM) and digital analysis of Pompe disease pathology. J Histochem Cytochem. 2005;53(1):63-73.
18. Phupong V, Shuangshoti S, Sutthiruangwong P, Maneesri S, Nuayboonma P, Shotelersuk V. Prenatal diagnosis of Pompe disease by electron microscopy. Arch Gynecol Obstet. 2005;271:259-261.
19. Schoser BGH, Muller-Hockert J, Horvath R, et al. Adult-onset glycogen storage disease type 2: Clinico-pathological phenotype revisited. Neuropathol Appl Neurobiol. 2007:33:544-559.
20. Raben N, Fukuda T, Gilbert AL, et al. Replacing acid alphaglucosidase in Pompe disease: Recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers. Mol Ther. 2005;11(1):48-56.
21. Thurberg BL, Maloney CL, Vaccaro C, et al. Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease. Lab Invest. 2006;86:1208-1220.
22. Winkel LPF, Kamphoven JHJ, van den Hout HJMP, et al. Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy. Muscle Nerve. 2003:27:743-751.
23. Nicolino MP, Peuch J-P, Kremer EJ, et al. Adenovirusmediated transfer of the acid-alpha-glucosidase gene into fibroblasts, myoblasts and myotubules from patients with glycogen storage disease type II leads to high level expression of enzyme and corrects glycogen accumulation. Hum Mol Genet. 1998;7(11):1695-1702.
24. Demo E, Frush D, Gottfried M, et al. Glycogen storage disease type III-hepatocellular carcinoma a long-term complication? J Hepatol. 2007;46:492-498.
25. Moses SW, Parvari R. The variable presentations of glycogen storage disease type IV: A review of clinical, enzymatic and molecular studies. Curr Mol Med. 2002;177-188.
26. Vucic S, Pamphlett R, Wills EJ, Yiannikas C. Polyglucosan body disease myopathy: An unusual presentation. Muscle Nerve. 2007;35:536-539.
27. Raben N, Dannon M, Lu N, et al. Surprises of genetic engineering: A possible model of polyglucosan body disease. Neurology. 2001;56:1739-1745.
28. Fowler DJ, Anderson G, Vellodi A, Malone M, Sebire NJ. Electron microscopy of chorionic villus samples for prenatal diagnosis of lysosomal storage disorders. Ultrastruct Pathol. 2007;31:15-21.
29. DiMauro S, Andreu AL, Bruno C, Hadjigeorgiou GM. Myophosphorylase deficiency (glycogenosis type V; McArdle disease). Curr Mol Med. 2002;2:189-196.
30. Gordon N. Glycogenosis type V or McArdle's disease. Dev Med Child Neurol. 2003;45:640-644.
31. Nakajima H, Raben N, Hamaguchi T, Yamasaki T. Phosphofructokinase deficiency: Past, present and future. Curr Mol Med. 2002;2:197-212.
32. Ellinwood NM, Vite CH, Haskins ME. Gene therapy for lysosomal storage diseases: The lessons and promise of animal models. J Gene Med. 2004:6:481-506.
33. Grompe M. Principles of therapeutic liver repopulation. J Inherit Metab Dis. 2006;29:421-425.
34. Weber A, Mahieu-Caputo D, Hadchouel M, Franco D. Hepatocyte transplantation: Studies in preclinical models. J Inhert Metab Dis. 2006;29:436-441.
35. Dhawan A, Mitry RR, Hughes RD. Hepatocyte transplantation for liver-based metabolic disorders. J Inherit Metab Dis. 2006;29:431-435.
36. Sokal E. Liver transplantation for inborn errors of liver metabolism. J Inherit Metab Dis. 2006;29:426-430.
37. Chen YT, Bali D, Sullivan J. Prenatal diagnosis of glycogen storage disease. Prenat Diagn. 2001;22:357-359.